Andreas P. Wagner Sells 14,878 Shares of Alignment Healthcare, Inc. (NASDAQ:ALHC) Stock

Alignment Healthcare, Inc. (NASDAQ:ALHC) insider Andreas P. Wagner sold 14,878 shares of the business’s stock in a transaction that occurred on Wednesday, February 12th. The stock was sold at an average price of $14.38, for a total value of $213,945.64. Following the sale, the insider now directly owns 200,885 shares in the company, valued at $2,888,726.30. This trade represents a 6.90 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link.

Alignment Healthcare Price Performance

NASDAQ:ALHC opened at $14.52 on Thursday. The firm has a market cap of $2.78 billion, a price-to-earnings ratio of -18.86 and a beta of 1.50. Alignment Healthcare, Inc. has a 12-month low of $4.46 and a 12-month high of $15.82. The company has a current ratio of 1.60, a quick ratio of 1.60 and a debt-to-equity ratio of 1.82. The company’s 50-day moving average is $12.88 and its two-hundred day moving average is $11.54.

Hedge Funds Weigh In On Alignment Healthcare

Several institutional investors and hedge funds have recently modified their holdings of the company. Cinctive Capital Management LP purchased a new stake in Alignment Healthcare in the 4th quarter worth approximately $336,000. Franklin Resources Inc. acquired a new stake in shares of Alignment Healthcare during the fourth quarter worth $732,000. Alliancebernstein L.P. grew its position in shares of Alignment Healthcare by 2.8% in the fourth quarter. Alliancebernstein L.P. now owns 119,440 shares of the company’s stock valued at $1,344,000 after purchasing an additional 3,300 shares during the period. Wellington Management Group LLP increased its stake in Alignment Healthcare by 77.9% in the fourth quarter. Wellington Management Group LLP now owns 7,438,500 shares of the company’s stock valued at $83,683,000 after purchasing an additional 3,257,630 shares during the last quarter. Finally, Arrowstreet Capital Limited Partnership lifted its position in Alignment Healthcare by 133.5% during the fourth quarter. Arrowstreet Capital Limited Partnership now owns 147,478 shares of the company’s stock worth $1,659,000 after buying an additional 84,315 shares during the period. Hedge funds and other institutional investors own 86.19% of the company’s stock.

Analysts Set New Price Targets

Several equities analysts recently issued reports on ALHC shares. Stephens reaffirmed an “overweight” rating and set a $17.00 price objective on shares of Alignment Healthcare in a report on Thursday, January 2nd. UBS Group lifted their price target on Alignment Healthcare from $9.00 to $12.00 and gave the stock a “neutral” rating in a research note on Wednesday, October 30th. Barclays increased their price objective on shares of Alignment Healthcare from $7.00 to $8.00 and gave the company an “underweight” rating in a research note on Wednesday, October 30th. Finally, Stifel Nicolaus lifted their target price on shares of Alignment Healthcare from $14.00 to $16.00 and gave the stock a “buy” rating in a research report on Tuesday, January 14th. One research analyst has rated the stock with a sell rating, two have given a hold rating, seven have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus price target of $11.88.

Alignment Healthcare Company Profile

Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.